Synthetic RIG-I-agonist RNA induces death of hepatocellular carcinoma cells
A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I ...
bournemouth.ac.uk16d
Institute of Medical Imaging and Visualisation
The Institute of Medical Imaging and Visualisation (IMIV) was established to support high quality research and education in the fields of medical imaging and medical visualisation. The IMIV is based ...
Frontiers17d
An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
Background: Hepatocellular carcinoma (HCC) is a common malignancy with high mortality worldwide. Despite advancements in diagnosis and treatment in recent years, there is still an urgent unmet need to ...
Nature24d
The FGF family: biology, pathophysiology and therapy
FGF receptors (FGFRs) are involved in the pathogenesis of cancer and skeletal ... Unfortunately, FGF19 transgenic mice develop hepatocellular carcinomas, and this side effect may impede the ...
eLife24d
Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis
The most common primary malignancy of the liver, hepatocellular carcinoma (HCC), is a heterogeneous tumor entity with high metastatic potential and complex pathophysiology. Increasing evidence ...
Frontiers24d
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
This case report presents a 57-year-old male with hepatocellular carcinoma who developed Type 1 Diabetes Mellitus ... This prompted a recommendation for further magnetic resonance imaging using the ...
The Lancet29d
Insights into the future of first-line advanced hepatocellular carcinoma treatment
aDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China bDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China ...